Eximore

Eximore is a dynamic biopharmaceutical company dedicated to the development and commercialization of innovative therapies for eye diseases. With a focus on pioneering solutions, Eximore utilizes its proprietary "pack and release" punctal plug technology to revolutionize ocular drug delivery. The company is committed to enhancing patient outcomes through the creation of non-invasive, sustained-release alternatives to traditional eye drops, addressing critical issues of patient adherence and compliance.

Located at Ha-Rav Shalom Shabazi St 26, Rosh Haayin, IL, Eximore is strategically positioned to become a key player in the ophthalmic space. The company’s dedication to consistent and reliable drug dosing is driving the advancement of its Glaucoma and Dry Eye products through Phase 2 clinical trials. Eximore’s innovative approach promises to significantly improve the standard of care for patients suffering from these conditions.

Eximore continues to expand its capabilities in ocular drug delivery and ophthalmic therapies, focusing on sustained delivery solutions that meet the evolving needs of patients and healthcare providers. The company is committed to developing cutting-edge treatments that enhance the quality of life for individuals with eye diseases. We invite the management team at Eximore to create a customized and exclusive company showcase and product listing on our platform to further highlight your advancements and connect with a wider audience.